Originally published Thursday, January 10, 2008 at 12:00 AM
Omeros plans $115 million IPO
Seattle-based biopharmaceutical company Omeros has filed for an initial public offering of stock, aiming to raise as much as $115 million...
Seattle Times staff
Seattle-based biopharmaceutical company Omeros has filed for an initial public offering of stock, aiming to raise as much as $115 million.
It is the first new IPO filing from a local company this year, and follows a rocky 2007 during which more initial offerings were withdrawn than were completed.
The company, founded in 1994, has no product revenue and no products approved for marketing.
It is developing compounds for inflammation and disorders of the central nervous system, specifically low-dosage proprietary combinations of therapeutic drugs that are delivered during surgery.
Its most advanced product candidates are targeted at arthroscopic, ophthalmological and urological surgery.
Proceeds of the IPO would be used, in part, to complete Phase 3 clinical trials of its leading candidate.
Omeros has spent $72 million since its inception, and had $27 million in available cash as of Sept. 30, according to the company's preliminary filing with the Securities and Exchange Commission.
The company did not give an estimated price or number of shares for its proposed offering, which is being underwritten by Deutsche Bank Securities, Pacific Growth Equities, Leerink Swann and Needham & Company.
Copyright © 2008 The Seattle Times Company
Rainier Pacific Financial calls rescue 'unlikely'
Clearwire gets $1.5B in financing from Sprint, others
NEW - 01:22 PM
Home prices fall nationwide, and in Seattle, in 3Q
UPDATE - 01:47 PM
Housing plan reaches 1 in 5 borrowers
NEW - 01:36 PM
Alaska Air Group believes smaller is better, CEO tells investors

Ken Auletta talks about "Googled"
Ken Auletta talks about Google with Brier Dudley at the Seattle Central Library.
nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
How to tell your office you're gravely ill
Post a comment
nwautos

Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment
- 'Missing' SeaTac man found with new name, in new state
- Police: DNA from officer's slaying matches suspect
- Lt. governor's son shot by co-worker in Kent; gunman then shot self
- DNA, ballistics tie man to cop killing, police say
- McGinn next Seattle mayor; Mallahan concedes as vote gap widens
- Prosecutors consider charges against suspect in police shooting
- Three more fires ignite in Greenwood
- Trucker dies as big-rig plummets off SF bridge
- Steve Kelley | Hasselbeck gives Seahawks' sagging season a stay of execution
- Huskies are finding talent in Tacoma
- Prosecutors prepare charges against suspect in police shooting
263 - Pelosi tours Seattle's Swedish after health-care vote
209 - King County OKs 'don't ask' law on immigration
209 - McGinn more than doubles his lead over Mallahan
192 - Resolute Fort Hood soldiers ready for return
130 - Time to bring Ken Griffey Jr. back in 2010
98 - Obama pressed into role as national healer
95 - 'Missing' SeaTac man found with new name, in new state
95 - Josh Smith picks UCLA
85 - DNA, ballistics tie man to cop killing, police say
83
- For 80-year-old Maple Valley man, hoops aren't just a dream
- Plans call for Triangle to become West Seattle gateway
- 'Missing' SeaTac man found with new name, in new state
- Three more fires ignite in Greenwood
- Silver Lake restaurant destroyed by fire
- House Speaker Nancy Pelosi tours Seattle's Swedish after health-care vote
- Pakistani-American cafe, bar owner on verge of being Granite Falls mayor
- All You Can Eat | Fruit flies: thrill to the kill
- McGinn next Seattle mayor; Mallahan concedes as vote gap widens
- Rainier Pacific Financial calls rescue 'unlikely'





